Dr. Barry Dworkin

AstraZeneca applies for approval of antibody treatment that provides passive immunity against COVID-19 for up to a year according to the press release. Indicated for vulnerable people who are immunocompromised or who have not responded to the vaccine.

Medical Mythbusting Commentary for November 4, 2021

Source:
Health Canada to review AstraZeneca’s antibody therapy that could prevent COVID-19

Related posts:

  1. Will Covid vaccine mixing be adopted as health policy? They use different delivery systems carrying the genetic instruction set to produce the same spike protein, ergo ongoing studies are evaluating clinical outcomes to determine if assumption is true.
  2. For those who have had AstraZeneca as their first dose, small Spanish study shows that using Pfizer as the second dose is safe and effective. More evaluation and other trials are ongoing but still, good news.
  3. Preprint study evaluated entire Scottish population and calls into question delaying second Covid vaccine dose up to 12 weeks. After first dose it noted a drop in preventing hospitalization from 84% at 5 weeks to 58% after the 7th. And after 16 weeks?
  4. End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.